With his views of the issue with regulations as they impact cigar manufacturers and President Trump’s efforts to cut back on regulations, it is the hope of many that the FDA’s growing influence over tobacco businesses. Many believe Gottlieb could be an ally to the premium cigar industry and could be good news for tobacco businesses hit with restricting rules, fines, and penalties. Critics, however, fear Gottlieb’s ties to several pharmaceutical companies could spell more issues for premium cigar manufacturers and the tobacco industry in general.
Gottlieb now faces a Senate vote and confirmation to move forward as the new leader of the FDA. To read his full 2012 opinion piece in support of the premium cigar industry, click here.